| Pain in Parkinson's disease: new concepts in pathogenesis and treatment K Rukavina, V Leta, C Sportelli, Y Buhidma, S Duty, M Malcangio, ... Current opinion in neurology 32 (4), 579-588, 2019 | 93 | 2019 |
| Potential of animal models for advancing the understanding and treatment of pain in Parkinson’s disease Y Buhidma, K Rukavina, KR Chaudhuri, S Duty NPJ Parkinson's disease 6 (1), 1, 2020 | 59 | 2020 |
| Animal models of Parkinson’s disease: a guide to selecting the optimal model for your research J Lama, Y Buhidma, EJR Fletcher, S Duty Neuronal Signaling 5 (4), NS20210026, 2021 | 44 | 2021 |
| Why are antidepressant drugs effective smoking cessation aids? M Shoaib, Y Buhidma Current Neuropharmacology 16 (4), 426-437, 2018 | 18 | 2018 |
| Age-related neurochemical and behavioural changes in D409V/WT GBA1 mouse: Relevance to lewy body dementia E Clarke, C Jantrachotechatchawan, Y Buhidma, M Broadstock, L Yu, ... Neurochemistry international 129, 104502, 2019 | 13 | 2019 |
| Varenicline, the clinically effective smoking cessation agent, restores probabilistic response reversal performance during withdrawal from nicotine A Jackson, S Silk, Y Buhidma, M Shoaib Addiction Biology 22 (5), 1316-1328, 2017 | 11 | 2017 |
| Periaqueductal grey and spinal cord pathology contribute to pain in Parkinson’s disease Y Buhidma, C Hobbs, M Malcangio, S Duty npj Parkinson's Disease 9 (1), 69, 2023 | 8 | 2023 |
| How can we improve on modeling nicotine addiction to develop better smoking cessation treatments? M Shoaib, Y Buhidma International Review of Neurobiology 126, 121-156, 2016 | 2 | 2016 |
| Insight gained from using animal models to study pain in Parkinson's disease. Y Buhidma, J Lama, S Duty International Review of Neurobiology 174, 99-118, 2024 | | 2024 |
| Investigating pain in Parkinson's disease and unravelling the underlying mechanisms YB Buhidma King's College London, 2022 | | 2022 |
